Title: Infliximab for Patients with Moderate to Severely Active Ulcerative Colitis: An Updated
Meta-Analysis of Randomized Controlled Trials
Version: 1 Date: 15 May 2025
Reviewer's report:
The authors applied comprehensive meta-analysis. They proposed infliximab with better
short/long-term clinical response, short/long-term clinical remission, short/long-term mucosal
healing on active ulcerative colitis than placebos, aminosalicylic acid preparations, steroids, or
immunosuppressive drugs, but shows no superiority in terms of adverse responses.
They comprehensive do researches and evidence quality grading. Besides, they had been point
the limitation of this meta-analusis.
Title: Infliximab for Patients with Moderate to Severely Active Ulcerative Colitis: An Updated
Meta-Analysis of Randomized Controlled Trials
Version: 1 Date: 15 May 2025
Reviewer's report:
The authors applied comprehensive meta-analysis. They proposed infliximab with better
short/long-term clinical response, short/long-term clinical remission, short/long-term mucosal
healing on active ulcerative colitis than placebos, aminosalicylic acid preparations, steroids, or
immunosuppressive drugs, but shows no superiority in terms of adverse responses.
They comprehensive do researches and evidence quality grading. Besides, they had been point
the limitation of this meta-analusis.
Please review this paper.
user
Title: Infliximab for Patients with Moderate to Severely Active Ulcerative Colitis: An Updated
Meta-Analysis of Randomized Controlled Trials
Version: 1 Date: 15 May 2025
Reviewer's report:
The authors applied comprehensive meta-analysis. They proposed infliximab with better
short/long-term clinical response, short/long-term clinical remission, short/long-term mucosal
healing on active ulcerative colitis than placebos, aminosalicylic acid preparations, steroids, or
immunosuppressive drugs, but shows no superiority in terms of adverse responses.
They comprehensive do researches and evidence quality grading. Besides, they had been point
the limitation of this meta-analusis.
assistant